Chris Seiter

Chris Seiter is an experienced finance professional currently serving as the Chief Corporate Finance Officer at RTW Investments, LP since April 2021. Prior to this role, Chris held the position of Chief Financial Officer at Trevi Therapeutics, Inc. from May 2018 to April 2021, and at MILLENDO THERAPEUTICS from September 2016 to April 2018. Early career experience includes over 17 years at Bank of America Merrill Lynch, culminating in the role of Managing Director, and an Associate Director position at UBS Investment Bank from January 1997 to June 1999. Chris Seiter earned a degree from the University of Rochester between 1984 and 1988.